<div style="max-width:860px;margin:20px auto;padding:0;border:1px solid #e9ecef;border-radius:15px;overflow:hidden;background:#fff;box-shadow:0 10px 30px rgba(0,0,0,0.08);line-height:1.6;word-break:keep-all;font-family:Pretendard,-apple-system,BlinkMacSystemFont,'Apple SD Gothic Neo','Noto Sans KR','Malgun Gothic','맑은 고딕',sans-serif;color:#333;"> <!-- ── HEADER ── --> <div style="width:100%;background:#f8f9fa;text-align:center;border-bottom:1px solid #e9ecef;"> <div style="padding:40px 20px;background:linear-gradient(135deg,#fff8f0 0%,#fff0e6 100%);"> <p style="margin:0 0 15px 0;color:#c0622a;font-size:13px;font-weight:800;letter-spacing:1px;">Only BRPInsight · Vol. 2026-03</p> <h1 style="margin:0;color:#1a1a1a;font-size:34px;font-weight:900;letter-spacing:-0.5px;line-height:1.3;"> 2026년 3월 <span style="color:#c0622a;">원외처방 매출</span><br>성장 분석 리포트 </h1> </div> <p style="margin:10px 15px 10px 0;font-size:12px;color:#888;text-align:right;">집계 기간 : 2026.02.01 – 03.31 | 데이터 출처 : BRPConnect | 작성자 : 에디터 L<br>DATA 문의 : help@brpinsight.com</p> </div> <!-- ── INTRO ── --> <div style="padding:30px 30px 10px;"> <div style="background:#f4f7fb;padding:25px;border-radius:12px;border:1px solid #dce6f2;margin-bottom:25px;"> <p style="margin-bottom:12px;line-height:1.8;font-size:15px;">안녕하세요. 에디터 L입니다.</p> <p style="margin-bottom:12px;line-height:1.8;font-size:15px;">BRPConnect 원외처방 데이터를 기반으로 집계한 2026년 3월 매출 성장 분석입니다. 2월 대비 3월 처방 금액 기준으로, 어떤 제품·브랜드·성분·시장군이 성장을 주도했는지 구조적으로 살펴봅니다.</p> <p style="margin-bottom:0;line-height:1.8;font-size:15px;">3월 전체 원외처방 시장은 <b>2.40조원</b>으로 2월(2.24조원) 대비 <b>+7.4%(+1,665억원)</b> 성장했습니다. 특히 당뇨병용제 단일 시장군이 전체 성장분의 <b>45.7%</b>를 차지하는 강력한 집중 성장 구조가 관찰됩니다.</p> </div> <!-- KPI CARDS --> <div style="display:flex;flex-wrap:wrap;gap:15px;margin-bottom:25px;"> <div style="flex:1;min-width:140px;background:#fff;border:1px solid #dee2e6;border-radius:10px;padding:20px;text-align:center;"> <p style="font-size:11px;color:#888;font-weight:bold;margin:0 0 8px 0;">2월 시장 규모</p> <p style="font-size:24px;font-weight:900;color:#1a1a1a;margin:0;">2.24조</p> <p style="font-size:12px;color:#666;margin:5px 0 0 0;">원외처방 금액</p> </div> <div style="flex:1;min-width:140px;background:#fff;border:1px solid #dee2e6;border-radius:10px;padding:20px;text-align:center;"> <p style="font-size:11px;color:#888;font-weight:bold;margin:0 0 8px 0;">3월 시장 규모</p> <p style="font-size:24px;font-weight:900;color:#c0622a;margin:0;">2.40조</p> <p style="font-size:12px;color:#666;margin:5px 0 0 0;">원외처방 금액</p> </div> <div style="flex:1;min-width:140px;background:#fff;border:1px solid #dee2e6;border-radius:10px;padding:20px;text-align:center;"> <p style="font-size:11px;color:#888;font-weight:bold;margin:0 0 8px 0;">MoM 성장</p> <p style="font-size:24px;font-weight:900;color:#dc3545;margin:0;">+7.4%</p> <p style="font-size:12px;color:#666;margin:5px 0 0 0;">+1,665억원</p> </div> <div style="flex:1;min-width:140px;background:#fff;border:1px solid #dee2e6;border-radius:10px;padding:20px;text-align:center;"> <p style="font-size:11px;color:#888;font-weight:bold;margin:0 0 8px 0;">TOP GROWER</p> <p style="font-size:24px;font-weight:900;color:#1a1a1a;margin:0;">+541억</p> <p style="font-size:12px;color:#666;margin:5px 0 0 0;">마운자로 브랜드</p> </div> </div> </div> <!-- ════════════ EP01: 제품·브랜드 ════════════ --> <div style="padding:10px 30px 20px;"> <div style="text-align:center;margin-bottom:30px;border-top:2px dashed #e9ecef;padding-top:35px;"> <span style="background:#c0622a;color:#fff;padding:5px 15px;border-radius:20px;font-size:13px;font-weight:bold;">PART 01</span> <h2 style="margin-top:15px;color:#1a1a1a;font-size:24px;letter-spacing:-0.5px;">제품·브랜드별 성장 현황</h2> <p style="color:#666;font-size:14px;margin-top:6px;">절대 성장액 TOP 10 · 성장률 TOP 10 · 브랜드 순위</p> </div> <!-- 마운자로 섹션 --> <h3 style="color:#1a1a1a;font-size:18px;font-weight:bold;margin:0 0 12px;padding-bottom:8px;border-bottom:2px solid #1a1a1a;">절대 성장액 TOP 10 제품</h3> <p style="color:#444;font-size:14.5px;line-height:1.8;margin:0 0 16px;">2월 기준 1억원 이상 처방 제품 중 3월 성장액 상위 순위입니다. 마운자로 5mg 단일 제품이 +481.8억(+213.9%)으로 압도적 1위를 기록했습니다.</p> <div style="margin:0 0 8px;overflow-x:auto;border-radius:10px;border:1px solid #e9ecef;"> <table style="width:100%;border-collapse:collapse;font-size:13px;text-align:left;min-width:540px;"> <thead> <tr style="background:#f8f9fa;border-bottom:2px solid #dee2e6;"> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:center;width:36px;">#</th> <th style="padding:11px 12px;color:#444;font-weight:bold;">제품명</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:center;">시장군</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">2월</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">3월</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">성장액(억)</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">성장률</th> </tr> </thead> <tbody> <tr style="border-bottom:1px solid #e9ecef;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#c0622a;">1</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">마운자로 5mg/0.5mL</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#fff0e6;color:#c0622a;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">당뇨병용제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">225.2</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">707.1</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+481.8</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-weight:bold;font-size:12px;">▲213.9%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">2</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">마운자로 10mg/0.5mL</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#fff0e6;color:#c0622a;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">당뇨병용제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">124.5</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">174.5</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+49.9</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲40.1%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">3</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">타이레놀정 500mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#e8f5e9;color:#2e7d32;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">해열·진통</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">31.9</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">59.5</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+27.6</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲86.6%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">4</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">플라빅스정 75mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#e3f2fd;color:#1565c0;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">동맥경화용제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">80.9</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">102.3</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+21.4</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲26.5%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">5</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">모노프로스트점안액 0.2mL</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#f3e8ff;color:#6b21a8;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">안과용제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">13.7</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">28.3</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+14.7</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲107.3%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">6</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">린파자정 150mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#fce8e8;color:#c62828;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">항악성종양제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">26.4</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">40.2</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+13.9</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲52.6%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">7</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">릭시아나정 30mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#e3f2fd;color:#1565c0;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">혈액응고저지제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">52.8</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">66.6</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+13.8</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲26.2%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">8</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">텔미누보정 40/2.5mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#e3f2fd;color:#1565c0;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">혈압강하제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">27.3</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">41.0</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+13.6</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲49.9%</td> </tr> <tr style="border-bottom:1px solid #e9ecef;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">9</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">타그리소정 80mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#fce8e8;color:#c62828;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">항악성종양제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">176.0</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">189.3</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+13.3</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲7.6%</td> </tr> <tr style="background:#fafafa;"> <td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">10</td> <td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">엑스탄디연질캡슐 40mg</td> <td style="padding:10px 12px;text-align:center;"><span style="background:#fce8e8;color:#c62828;font-size:11px;padding:2px 7px;border-radius:10px;font-weight:bold;">항악성종양제</span></td> <td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">34.4</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;">47.6</td> <td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+13.1</td> <td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲38.1%</td> </tr> </tbody> </table> </div> <!-- 마운자로 뉴스 인사이트 박스 --> <div style="margin:16px 0 28px;padding:18px 20px;border-radius:10px;background:#fff8f0;border:1px solid #ffdcb8;border-left:5px solid #c0622a;"> <p style="font-size:13px;font-weight:bold;color:#c0622a;margin:0 0 8px 0;">📰 마운자로 관련 주요 뉴스 · 인사이트</p> <p style="font-size:13.5px;color:#555;line-height:1.7;margin:0 0 10px 0;">마운자로(티르제파티드)는 2025년 8월 한국 출시 이후 폭발적 수요로 초기부터 수급 불안이 지속됐습니다. 현재 비급여 비만·당뇨 치료제로 공급 중이며, 3월 5mg 용량의 +214% 급등은 초기 용량 신규 진입 환자의 폭증을 반영합니다.</p> <div style="display:flex;flex-wrap:wrap;gap:8px;"> <a href="https://medicalworldnews.co.kr/m/view.php?idx=1510969434" target="_blank" style="font-size:12px;color:#c0622a;text-decoration:none;background:#fff;border:1px solid #ffdcb8;padding:4px 10px;border-radius:6px;display:inline-block;">한국릴리 마운자로 국내 출시 & 기대·주의 병존 →</a> <a href="https://www.dailypharm.com/user/news/2964" target="_blank" style="font-size:12px;color:#c0622a;text-decoration:none;background:#fff;border:1px solid #ffdcb8;padding:4px 10px;border-radius:6px;display:inline-block;">마운자로 약국 입고 현황 & 가격 형성 →</a> <a href="https://news.nate.com/view/20250710n02907" target="_blank" style="font-size:12px;color:#c0622a;text-decoration:none;background:#fff;border:1px solid #ffdcb8;padding:4px 10px;border-radius:6px;display:inline-block;">마운자로 국내 상륙 임박 & 비만치료제 경쟁 →</a> </div> </div> <!-- 브랜드 TOP 10 --> <h3 style="color:#1a1a1a;font-size:18px;font-weight:bold;margin:0 0 12px;padding-bottom:8px;border-bottom:2px solid #1a1a1a;">브랜드별 성장 TOP 10</h3> <p style="color:#444;font-size:14.5px;line-height:1.8;margin:0 0 16px;">마운자로 제외 시 고지혈증 복합제 4개 브랜드(로수젯·아토젯·로수바미브·리피토) 합산 +103억이 두드러집니다. 타이레놀(+35.9%)과 조인스(+43.0%)의 봄철 급등도 주목할 만합니다.</p> <div style="margin:0 0 8px;overflow-x:auto;border-radius:10px;border:1px solid #e9ecef;"> <table style="width:100%;border-collapse:collapse;font-size:13px;text-align:left;min-width:500px;"> <thead> <tr style="background:#f8f9fa;border-bottom:2px solid #dee2e6;"> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:center;width:36px;">#</th> <th style="padding:11px 12px;color:#444;font-weight:bold;">브랜드</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">2월(억)</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">3월(억)</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">성장액(억)</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">성장률</th> </tr> </thead> <tbody> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#c0622a;">1</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">마운자로</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">907.3</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">1,448.5</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+541.2</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲59.7%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">2</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">로수젯</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">170.7</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">207.4</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+36.8</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲21.5%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">3</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">릭시아나</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">93.5</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">121.8</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+28.3</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲30.3%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">4</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">타이레놀</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">73.0</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">99.1</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+26.2</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲35.9%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">5</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">아토젯</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">103.8</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">129.5</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+25.6</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲24.7%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">6</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">플라빅스</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">95.9</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">117.6</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+21.6</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲22.6%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">7</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">케이캡</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">189.8</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">211.1</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+21.3</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲11.2%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">8</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">로수바미브</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">96.9</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">117.7</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+20.8</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲21.4%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">9</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">조인스</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">47.6</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">68.0</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+20.4</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲43.0%</td></tr> <tr style="background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">10</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">리피토</td><td style="padding:10px 12px;text-align:right;font-size:12px;color:#666;">132.5</td><td style="padding:10px 12px;text-align:right;font-weight:bold;">152.9</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+20.4</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲15.4%</td></tr> </tbody> </table> </div> <!-- 브랜드별 뉴스 링크 카드들 --> <div style="display:flex;flex-direction:column;gap:12px;margin:20px 0 30px;"> <!-- 타이레놀 --> <div style="background:#fff;border:1px solid #e9ecef;border-radius:10px;padding:16px 18px;border-left:4px solid #2e7d32;"> <p style="font-size:12px;font-weight:bold;color:#2e7d32;margin:0 0 6px 0;">📰 타이레놀 · 해열진통제 뉴스</p> <p style="font-size:13px;color:#555;line-height:1.6;margin:0 0 10px 0;">타이레놀 500mg은 3월 +86.6% 급등. 봄철 환절기 수요 집중과 더불어 110정 대용량 패키지 출시(약국 전용)가 소비자 인지도를 높이며 처방 수요 확대에 기여한 것으로 판단됩니다.</p> <div style="display:flex;flex-wrap:wrap;gap:6px;"> <a href="https://www.kpanews.co.kr/article/show.asp?idx=255625" target="_blank" style="font-size:11px;color:#2e7d32;text-decoration:none;background:#e8f5e9;border:1px solid #c8e6c9;padding:3px 9px;border-radius:5px;">타이레놀 500mg 110정 대용량 출시 →</a> <a href="https://www.bizhankook.com/bk/article/27969" target="_blank" style="font-size:11px;color:#2e7d32;text-decoration:none;background:#e8f5e9;border:1px solid #c8e6c9;padding:3px 9px;border-radius:5px;">공급 재개된 의약품 16%에 불과 (의약품 수급 현황) →</a> </div> </div> <!-- 케이캡 --> <div style="background:#fff;border:1px solid #e9ecef;border-radius:10px;padding:16px 18px;border-left:4px solid #1565c0;"> <p style="font-size:12px;font-weight:bold;color:#1565c0;margin:0 0 6px 0;">📰 케이캡 뉴스</p> <p style="font-size:13px;color:#555;line-height:1.6;margin:0 0 10px 0;">케이캡(테고프라잔)은 3월 211억원을 기록하며 P-CAB 1위를 수성. 2025년 신규 적응증(유지요법) 허가와 물질특허 2031년까지 연장으로 제네릭 진입 방어에 성공. 미국 NDA 신청이 임박한 상황으로 2026년 글로벌 모멘텀이 주목됩니다.</p> <div style="display:flex;flex-wrap:wrap;gap:6px;"> <a href="https://www.biotimes.co.kr/news/articleView.html?idxno=8310" target="_blank" style="font-size:11px;color:#1565c0;text-decoration:none;background:#e3f2fd;border:1px solid #bbdefb;padding:3px 9px;border-radius:5px;">케이캡 적응증 확대 허가 →</a> <a href="https://www.medicopharma.co.kr/news/articleView.html?idxno=66681" target="_blank" style="font-size:11px;color:#1565c0;text-decoration:none;background:#e3f2fd;border:1px solid #bbdefb;padding:3px 9px;border-radius:5px;">케이캡 2026년 해외 성과 전망 (미국 NDA·중국 보험) →</a> <a href="https://www.doctorsnews.co.kr/news/articleView.html?idxno=154924" target="_blank" style="font-size:11px;color:#1565c0;text-decoration:none;background:#e3f2fd;border:1px solid #bbdefb;padding:3px 9px;border-radius:5px;">케이캡 물질특허 2031년까지 확보 →</a> </div> </div> <!-- 타그리소·린파자 --> <div style="background:#fff;border:1px solid #e9ecef;border-radius:10px;padding:16px 18px;border-left:4px solid #c62828;"> <p style="font-size:12px;font-weight:bold;color:#c62828;margin:0 0 6px 0;">📰 타그리소 · 린파자 뉴스</p> <p style="font-size:13px;color:#555;line-height:1.6;margin:0 0 10px 0;">타그리소는 2025년 1월 비소세포폐암 1차 치료제 건강보험 급여 적용 이후 처방이 안정적으로 확대 중입니다. 렉라자와의 시장 양분 구도가 형성되며 2026년 1,300억원 이상의 처방 실적이 기대됩니다. 린파자(올라파립)는 PARP억제제로 난소암·유방암 유지요법 처방이 꾸준히 증가세입니다.</p> <div style="display:flex;flex-wrap:wrap;gap:6px;"> <a href="http://www.monews.co.kr/news/articleView.html?idxno=329951" target="_blank" style="font-size:11px;color:#c62828;text-decoration:none;background:#fce8e8;border:1px solid #ffcdd2;padding:3px 9px;border-radius:5px;">타그리소·렉라자 1차 치료 급여 성장 전망 →</a> <a href="https://www.doctorsnews.co.kr/news/articleView.html?idxno=142456" target="_blank" style="font-size:11px;color:#c62828;text-decoration:none;background:#fce8e8;border:1px solid #ffcdd2;padding:3px 9px;border-radius:5px;">린파자 급여 확대 현황 →</a> </div> </div> <!-- 릭시아나·DOAC --> <div style="background:#fff;border:1px solid #e9ecef;border-radius:10px;padding:16px 18px;border-left:4px solid #546e7a;"> <p style="font-size:12px;font-weight:bold;color:#546e7a;margin:0 0 6px 0;">📰 릭시아나 · DOAC 항응고제 뉴스</p> <p style="font-size:13px;color:#555;line-height:1.6;margin:0 0 10px 0;">릭시아나(에독사반)는 3월 30mg·60mg 합산 +28.3억(▲30.3%) 성장. Factor Xa 억제제 시장 전체가 +26.6% 급성장하며 와파린→DOAC 전환이 가속화되는 추세입니다. 출혈 위험 모니터링 관련 임상 데이터도 축적되고 있습니다.</p> <div style="display:flex;flex-wrap:wrap;gap:6px;"> <a href="https://www.monews.co.kr/news/articleView.html?idxno=327285" target="_blank" style="font-size:11px;color:#546e7a;text-decoration:none;background:#eceff1;border:1px solid #cfd8dc;padding:3px 9px;border-radius:5px;">DOAC 처방 후 출혈 위험 분석 →</a> </div> </div> </div> </div> <!-- ════════════ PART 02: 시장군 ════════════ --> <div style="padding:10px 30px 20px;"> <div style="text-align:center;margin-bottom:30px;border-top:2px dashed #e9ecef;padding-top:35px;"> <span style="background:#2e7d32;color:#fff;padding:5px 15px;border-radius:20px;font-size:13px;font-weight:bold;">PART 02</span> <h2 style="margin-top:15px;color:#1a1a1a;font-size:24px;letter-spacing:-0.5px;">시장군별 구조 변화</h2> <p style="color:#666;font-size:14px;margin-top:6px;">당뇨병용제 +761억 · 동맥경화용제 +497.8억 · 혈압강하제 +278.7억</p> </div> <!-- 시장군 KPI --> <div style="display:flex;flex-wrap:wrap;gap:15px;margin-bottom:20px;"> <div style="flex:1;min-width:130px;background:#fff8f0;border:1px solid #ffdcb8;border-radius:10px;padding:18px;text-align:center;"> <p style="font-size:11px;color:#c0622a;font-weight:bold;margin:0 0 6px 0;">당뇨병용제 (1위)</p> <p style="font-size:22px;font-weight:900;color:#1a1a1a;margin:0;">+761억</p> <p style="font-size:11px;color:#888;margin:4px 0 0 0;">전체 성장의 45.7%</p> </div> <div style="flex:1;min-width:130px;background:#f4f7fb;border:1px solid #dce6f2;border-radius:10px;padding:18px;text-align:center;"> <p style="font-size:11px;color:#1565c0;font-weight:bold;margin:0 0 6px 0;">동맥경화용제 (2위)</p> <p style="font-size:22px;font-weight:900;color:#1a1a1a;margin:0;">+497.8억</p> <p style="font-size:11px;color:#888;margin:4px 0 0 0;">최대 규모 시장군</p> </div> <div style="flex:1;min-width:130px;background:#e8f5e9;border:1px solid #c8e6c9;border-radius:10px;padding:18px;text-align:center;"> <p style="font-size:11px;color:#2e7d32;font-weight:bold;margin:0 0 6px 0;">혈압강하제 (3위)</p> <p style="font-size:22px;font-weight:900;color:#1a1a1a;margin:0;">+278.7억</p> <p style="font-size:11px;color:#888;margin:4px 0 0 0;">▲15.7% 성장</p> </div> </div> <!-- 시장군 바 차트 --> <div style="margin:0 0 25px;background:#f8f9fa;padding:22px;border:1px solid #e9ecef;border-radius:12px;"> <p style="font-size:13px;font-weight:bold;color:#666;margin:0 0 18px 0;">📊 시장군별 3월 성장액 (억원)</p> <div style="display:flex;align-items:center;gap:10px;margin-bottom:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">당뇨병용제</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:100%;height:100%;background:#c0622a;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size:11px;color:#fff;font-weight:bold;">+761.1억 (▲35.2%)</span></div> </div> </div> <div style="display:flex;align-items:center;gap:10px;margin-bottom:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">동맥경화용제</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:65.4%;height:100%;background:#1565c0;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size:11px;color:#fff;font-weight:bold;">+497.8억 (▲17.4%)</span></div> </div> </div> <div style="display:flex;align-items:center;gap:10px;margin-bottom:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">혈압강하제</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:36.6%;height:100%;background:#2e7d32;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size:11px;color:#fff;font-weight:bold;">+278.7억 (▲15.7%)</span></div> </div> </div> <div style="display:flex;align-items:center;gap:10px;margin-bottom:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">기타중추신경용약</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:15.9%;height:100%;background:#6f42c1;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size: 7pt; color: rgb(255, 255, 255); font-weight: bold;">+121.1억 (▲11.7%)</span></div> </div> </div> <div style="display:flex;align-items:center;gap:10px;margin-bottom:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">항악성종양제</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:15.3%;height:100%;background:#dc3545;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size: 7pt; color: rgb(255, 255, 255); font-weight: bold;">+116.5억(▲12.0%)</span></div> </div> </div> <div style="display:flex;align-items:center;gap:10px;margin-bottom:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">안과용제</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:14.1%;height:100%;background:#fd7e14;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size: 6pt; color: rgb(255, 255, 255); font-weight: bold;">+107.7억(▲12.6%)</span></div> </div> </div> <div style="display:flex;align-items:center;gap:10px;"> <span style="width:130px;font-size:12px;font-weight:bold;color:#444;text-align:right;">혈액응고저지제</span> <div style="flex:1;background:#e9ecef;height:22px;border-radius:11px;overflow:hidden;"> <div style="width:6.4%;height:100%;background:#546e7a;display:flex;align-items:center;padding-left:10px;box-sizing:border-box;"><span style="font-size:6px;color:#fff;font-weight:bold;">+48.4억 (▲26.6%)</span></div> </div> </div> </div> <!-- 약가 제도 뉴스 --> <div style="margin:0 0 30px;padding:18px 20px;border-radius:10px;background:#f4f7fb;border:1px solid #dce6f2;border-left:5px solid #1565c0;"> <p style="font-size:13px;font-weight:bold;color:#1565c0;margin:0 0 8px 0;">📰 2026년 제도·정책 변화 — 약가 개편 이슈</p> <p style="font-size:13.5px;color:#555;line-height:1.7;margin:0 0 10px 0;">2026년 하반기 약가 개편 1차 조정이 예정되어 있으며, 제네릭 산정률 조정 방향에 제약업계와 환자단체 간 논쟁이 이어지고 있습니다. 혁신형 기업은 최대 4년간 현행 산정률 적용 예외를 받을 수 있어 오리지널 품목 처방에 미치는 영향이 주목됩니다.</p> <a href="https://econmingle.com/news/generic-drug-price-reform-criticism-2026/" target="_blank" style="font-size:11px;color:#1565c0;text-decoration:none;background:#fff;border:1px solid #bbdefb;padding:3px 9px;border-radius:5px;display:inline-block;">14년 만의 약가 개편 — 환자·소비자 반응 →</a> </div> </div> <!-- ════════════ PART 03: 성분군 ════════════ --> <div style="padding:10px 30px 30px;"> <div style="text-align:center;margin-bottom:30px;border-top:2px dashed #e9ecef;padding-top:35px;"> <span style="background:#1565c0;color:#fff;padding:5px 15px;border-radius:20px;font-size:13px;font-weight:bold;">PART 03</span> <h2 style="margin-top:15px;color:#1a1a1a;font-size:24px;letter-spacing:-0.5px;">성분군별 트렌드 — 복합제의 시대</h2> <p style="color:#666;font-size:14px;margin-top:6px;">ATC5 성분군 TOP 집계 · 복합제 vs 단독제 성장률 비교</p> </div> <div style="margin:0 0 20px;padding:20px;border-radius:10px;background:#f8f9fa;border:1px solid #e9ecef;border-left:4px solid #1a1a1a;"> <p style="font-size:13px;font-weight:bold;color:#1a1a1a;margin:0 0 8px 0;">복합제 vs 단독제 — 성장률 비교</p> <p style="font-size:14px;color:#555;line-height:1.8;margin:0;"> 지질강하: <strong>복합제 +18.9%</strong> vs 스타틴 단독 +15.6%<br> 혈당강하: <strong>경구 복합제 +17.3%</strong> — 메트포르민+SGLT2i, DPP-4i 조합 처방 확대<br> 항응고제: <strong>Factor Xa 억제제 +27.0%</strong> — DOAC 전환 가속 명확<br> 항치매: <strong>기타 항치매제 +11.7%</strong> — 글리아타민·종근당글리아티린 계열 성장 </p> </div> <div style="margin:0 0 20px;overflow-x:auto;border-radius:10px;border:1px solid #e9ecef;"> <table style="width:100%;border-collapse:collapse;font-size:13px;text-align:left;min-width:520px;"> <thead> <tr style="background:#f8f9fa;border-bottom:2px solid #dee2e6;"> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:center;width:36px;">#</th> <th style="padding:11px 12px;color:#444;font-weight:bold;">성분군 (ATC5)</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">성장액(억)</th> <th style="padding:11px 12px;color:#444;font-weight:bold;text-align:right;">성장률</th> </tr> </thead> <tbody> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#c0622a;">1</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">비만·체중조절 기타약제 <span style="font-weight:normal;color:#888;font-size:12px;">(티르제파티드)</span></td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+546.9</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲45.7%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">2</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">복합 지질강하제 <span style="font-weight:normal;color:#888;font-size:12px;">(스타틴+에제티미브)</span></td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+253.8</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲18.9%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">3</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">양성자펌프억제제 PPI</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+133.5</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲13.7%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">4</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">HMG CoA 환원효소억제제 <span style="font-weight:normal;color:#888;font-size:12px;">(스타틴 단독)</span></td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+133.1</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲15.6%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">5</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">항혈소판제 <span style="font-weight:normal;color:#888;font-size:12px;">(클로피도그렐·티카그렐러)</span></td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+129.4</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲16.4%</td></tr> <tr style="border-bottom:1px solid #e9ecef;background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">6</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">ARB+CCB 복합 혈압강하제</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+122.4</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲15.9%</td></tr> <tr style="border-bottom:1px solid #e9ecef;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">7</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">경구 혈당강하 복합제 <span style="font-weight:normal;color:#888;font-size:12px;">(메트포르민+SGLT2i 등)</span></td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+91.7</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲17.3%</td></tr> <tr style="background:#fafafa;"><td style="padding:10px 12px;text-align:center;font-weight:bold;color:#888;">8</td><td style="padding:10px 12px;font-weight:bold;color:#1a1a1a;">직접 Factor Xa 억제 항응고제</td><td style="padding:10px 12px;text-align:right;font-weight:bold;color:#dc3545;">+47.5</td><td style="padding:10px 12px;text-align:right;color:#dc3545;font-size:12px;font-weight:bold;">▲27.0%</td></tr> </tbody> </table> </div> <div style="margin:0 0 20px;padding:18px 20px;border-radius:10px;background:#fff9f5;border:1px solid #ffdcb8;border-left:5px solid #c0622a;"> <p style="font-size:13px;font-weight:bold;color:#c0622a;margin:0 0 6px 0;">💡 핵심 인사이트 — 복합제 우위 구조 고착화</p> <p style="font-size:13.5px;color:#555;line-height:1.7;margin:0;">지질강하·혈당강하·혈압강하 세 영역 모두에서 복합 성분군이 단독 성분군의 성장률을 앞서거나 동등한 수준을 기록했습니다. 처방 편의성·복약 순응도를 이유로 임상에서 복합제 처방 선호가 구조적으로 자리잡은 것으로 분석됩니다.</p> </div> </div> <!-- FOOTER --> <div style="background:#f8f9fa;padding:22px 30px;border-top:1px solid #e9ecef;text-align:center;"> <p style="font-size:12px;color:#888;margin:0;line-height:1.6;"> 데이터 출처: BRPConnect | 2026년 2월 1일~3월 31일 집계 기준 | 원외처방 PRICE 기준 | 총 53,334개 제품 레코드 분석<br> 본 콘텐츠는 제약·의료 마케팅 전문가를 대상으로 하며, 처방 결정은 임상 상황에 따라 판단하시기 바랍니다. </p> </div> </div>